AdMare BioInnovations recently announced the official opening of the Vancouver-based organization’s M4 Innovation Centre.
The turnkey facility in Mount Pleasant is purpose-built to support the development of innovative life sciences companies with the potential to scale and anchor long‑term economic activity, according to a statement from the B.C. firm.
Developed with financial support from the Government of British Columbia and the Government of Canada through PacifiCan, the 30,000-square-foot M4 Innovation Centre provides wet lab space for early-stage and growing life sciences companies.
“By investing in world‑class infrastructure, we’re helping local companies scale, create good jobs, and bring made‑in‑B.C. innovations to patients and markets around the world,” said Ravi Kahlon, Minister of Jobs and Economic Growth.
“These wet labs provide the space and equipment companies need to move from research to commercialization,” Kahlon says, “helping to propel them forward and cement B.C.‘s position as a hub and leader in life sciences.”
The centre features turnkey wet labs, office and collaboration space, shared scientific equipment, and a flexible design that can evolve as companies grow.
“B.C.’s life sciences sector is driven by talented researchers, entrepreneurs, and innovators who are turning bold ideas into real‑world solutions,” stated Gregor Robertson, Minister responsible for Pacific Economic Development Canada. “The new adMare M4 Innovation Centre gives local companies access to the specialized lab space they need to accelerate growth, attract investment, and bring life-changing discoveries to market.”
With construction now complete, three companies have so far taken occupancy at the M4 Innovation Centre.
Over the initial five years, the facility is expected to support more than twenty companies.
“Move-in ready lab space gives companies the ability to focus on their science and build value,” commented Matthew Carlyle, chief executive officer of adMare. “When teams can move faster and demonstrate progress earlier, they become more attractive to investors and better positioned for growth; adMare Innovation Centres are designed to support that progression.”
AdMare BioInnovations utilizes commercial expertise, specialized R&D infrastructure, and seed capital to support life sciences companies and industry-ready talent.
To date, adMare has helped create 39 companies that have attracted $2.5 billion in capital, achieved a combined value of $5.8 billion, and created 1,000 jobs.
Leave a Reply